Luca Saba on Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification
Luca Saba, Dean of School of Medicine at the University of Cagliari, shared a post on LinekedIn:
”New publication in JAMA Cardiology
Together with Peter Libby, we explore a long-standing assumption in stroke medicine that may need revision.
For decades, carotid artery disease has been considered responsible for only a small fraction of ischemic strokes, typically those associated with high-grade stenosis.
This view shaped both clinical guidelines and epidemiologic data.
We argue that this framework introduces a systematic bias in how stroke risk is assessed and attributed.
A significant number of ischemic strokes may in fact originate from nonstenotic but biologically high-risk carotid plaques: lesions characterized by hemorrhage, inflammation, or surface ulceration, which traditional stenosis-based classifications fail to capture.
This conceptual bias affects not only clinical decision-making, potentially excluding at-risk patients from early intervention, but also epidemiologic estimates and public health planning, by underestimating the true contribution of carotid atherosclerosis to the global burden of stroke.
We propose that plaque-centered risk models, such as the recently introduced Carotid Plaque–RADS, can complement traditional stenosis thresholds by integrating compositional and morphological information from CT, MRI, and ultrasound.
This work calls for a shift from a purely geometric definition of disease to a biological and predictive model, one that better reflects the mechanisms underlying ischemic events and may improve prevention strategies worldwide.”
Read the full article here.
Article: Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification
Authors: Luca Saba, Peter Libby
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy